Treatment of Non-Small-Cell Lung Cancer with Erlotinib following Gefitinib-Induced Hepatotoxicity: Review of 8 Clinical Cases

Objective. Gefitinib often induces liver damage. A few reports have described that the subsequent administration of erlotinib was associated with less hepatotoxicity, but the safety and efficacy of this treatment are still not fully investigated. Therefore, we evaluated retrospectively the patients...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Lung Cancer Int
Asıl Yazarlar: Yano, Yukihiro, Namba, Yoshinobu, Mori, Masahide, Nakazawa, Yukie, Nashi, Ayumi, Kagami, Shinichi, Niinaka, Manabu, Yoneda, Tsutomu, Kimura, Hiromi, Yamaguchi, Toshihiko, Yokota, Soichiro
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Hindawi Publishing Corporation 2012
Konular:
Clinical Study
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4437396/
https://ncbi.nlm.nih.gov/pubmed/26316933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/354657
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller